Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

B cells and antibodies in progressive multiple sclerosis: Contribution to neurodegeneration and progression.
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
Development and feasibility of the Help to Overcome Problems Effectively (HOPE) self-management intervention for people living with multiple sclerosis.
Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields.
Factitious Graves' disease due to biotin immunoassay interference - A case and review of the literature.
Re: The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study.
High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
Fatigue in Multiple Sclerosis: Misconceptions and Future Research Directions.
TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis.
Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis.
Myelinating glia differentiation is regulated by extracellular matrix elasticity.
Linked Patient-Reported Outcomes Data From Patients With Multiple Sclerosis Recruited on an Open Internet Platform to Health Care Claims Databases Identifies a Representative Population for Real-Life Data Analysis in Multiple Sclerosis.
Cadm3 (Necl-1) interferes with the activation of the PI3 kinase/Akt signaling cascade and inhibits Schwann cell myelination in vitro.
CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags.
[Multiple sclerosis vaccine: possibilities of the use of dendritic cells immunomodulatory potential].
Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.
Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex.
Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial.
Effect of interferon-β1α therapy on multiple sclerosis based on gadolinium-enhancing or active T2 magnetic resonance imaging outcomes: a meta-analysis.
[Factors Influencing Lead Time in Multiple Sclerosis: Survey of Members of the German Multiple Sclerosis Society in Saxony-Anhalt].
Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.
Association Between Intellectual Capacity And Fatigue In Persons With Multiple Sclerosis: 1292 Board #4 June 2, 8: 00 AM - 10: 00 AM.
How long does it take to diagnose patients with neuromyelitis optica (NMO) using the 2006 diagnostic criteria?
Neurological Manifestations in Familial Mediterranean Fever: Results of 22 Children from a Reference Center in Kayseri, an Urban Area in Central Anatolia, Turkey.
Delayed iron deposit and atrophy of the putamen in a case with osmotic demyelination syndrome.

Pages